Ravi Ujjinamatada

Ravi Ujjinamatada has extensive work experience in the field of medicinal chemistry, spanning over two decades. Ravi has held various leadership roles in companies like Cellarity, Organix Inc., Aurigene Oncology Limited, and academic institutions like the University of Maryland Baltimore County, Indian Institute of Technology, Bombay, and Gulbarga University. Their expertise includes developing novel compounds for the treatment of late-stage cancers, viral and cancer indications, and antimicrobial and analgesic activities.

Ravi Ujjinamatada completed a Master's Degree in Organic Chemistry at Gulbarga University in 1996, followed by a Doctor of Philosophy (PhD) in Synthetic Studies in Benzofurans at the same university from 1997 to 2002. Later, they pursued a Research Associate position at the Indian Institute of Technology, Bombay from 2000 to 2001. In 2002, they continued their research as a Postdoctoral Researcher at the University of Maryland Baltimore County until 2008. Most recently, from 2020 to 2022, they obtained a Biotechnology Management Graduate Certificate from the Harvard Extension School in the field of Biotechnology.